Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00696280 · ClinicalTrials.gov registry record
Observational Study of Delayed Nausea and Vomiting
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 106
- Enrollment target
NCT00696280 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 106 participants.
The verdict
NCT00696280 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
Delayed emesis following administration of carboplatin-based chemotherapy despite prophylaxis with standard antiemetic prophylaxis (5-HT3 and corticosteroid) remains a clinically significant and distressing problem for patients with cancer. The incidence of delayed emesis appears to be higher in women compared to men.
Interventions
- BEHAVIORAL Functional Living Index - Emesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00696280
The ClinicalTrials.gov registry entry for NCT00696280 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Functional Living Index - Emesis is the first listed.
NCT00696280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00696280 about?
NCT00696280 is a clinical study titled "Observational Study of Delayed Nausea and Vomiting". Delayed emesis following administration of carboplatin-based chemotherapy despite prophylaxis with standard antiemetic prophylaxis (5-HT3 and corticosteroid) remains a clinically significant and distressing problem for patients with cancer. The incidence of delayed emesis appears to be higher in wom...
What is the current status of trial NCT00696280?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2006-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00696280?
The interventions under investigation include: Functional Living Index - Emesis (BEHAVIORAL).
Who is sponsoring clinical trial NCT00696280?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.